At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life.

When Novo Nordisk introduced Ozempic to the world, investors jumped on board, recognizing the significant impact this diabetes drug could have on patients seeking help with weight-loss. It began ...

Novo Nordisk A/S (NYSE:NVO) said its first quarter of 2026 was marked by rapid uptake of its newly launched Wegovy pill in the U.S., continued expansion of its obesity franchise and a series of ...

Adding to the company's woes is Novo Nordisk's weak guidance for 2026. Unlike Eli Lilly, which offered strong guidance, Novo Nordisk is expecting revenue and earnings to fall this year. Part of that ...